首页 › 基金 › SECTOR GAMMA AS › CRNX

SECTOR GAMMA AS 对 CRNX 的持仓历史

CRINETICS PHARMACEUTICALS IN

SECTOR GAMMA AS 在 Q2 2026 的 13F 申报中披露持有 CRNX(CRINETICS PHARMACEUTICALS IN)114,628 股,市值约 US$4.3M,约占其申报组合的 0.93%,在其申报持仓中市值排名第 34 位。 SECTOR GAMMA AS 最近 3 个申报季度中有 3 个季度披露了 CRNX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)114.63K 股
申报持仓市值$4.29M
组合权重0.93%
首次申报Q4 2025
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

SECTOR GAMMA AS 对 CRNX 的持仓演变

SECTOR GAMMA AS 于 Q4 2025 首次披露 CRNX 持仓:115,000 股(约 US$5.4M)。 在 3 次申报中,SECTOR GAMMA AS 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 114,628 股、市值约 US$4.3M,环比增持 20,433 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 115.00K $5.35M 新进
Q1 2026 94.19K $3.42M 减持
Q2 2026 114.63K $4.29M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CRNX 与 13F 数据

CRNX(CRINETICS PHARMACEUTICALS IN)的行业分类暂缺。我们追踪的基金中还有 38 只申报持有 CRNX,申报仓位最大的包括:法拉龙资本管理 (US$336.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$336.4M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$241.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CRNX 的基金

查看 CRNX 的全部基金持有人 →

常见问题

How long has SECTOR GAMMA AS held CRNX?

SECTOR GAMMA AS has disclosed CRNX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SECTOR GAMMA AS's current position in CRNX?

As of Q2 2026, SECTOR GAMMA AS holds 114.63K shares of CRNX (CRINETICS PHARMACEUTICALS IN), valued at $4.29M, representing 0.93% of its reported portfolio and ranking #34.

Has SECTOR GAMMA AS been buying or selling CRNX?

In the latest 13F filing (Q2 2026), SECTOR GAMMA AS increased its position in CRNX.

Which other funds hold CRNX?

Other major institutional holders of CRNX include 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.